Cutler Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,000
Closed -$5K 4238
2023
Q3
$5K Buy
+3,000
New +$86.6K ﹤0.01% 2868
2022
Q4
Sell
-2,900
Closed -$5K 5097
2022
Q3
$5K Sell
2,900
-1,500
-34% -$58K ﹤0.01% 3689
2022
Q2
$5K Buy
4,400
+2,500
+132% +$83.8K ﹤0.01% 3755
2022
Q1
$1K Buy
+1,900
New +$71.4K ﹤0.01% 5058
2021
Q4
Sell
-1,700
Closed -$1K 5961
2021
Q3
$1K Sell
1,700
-3,700
-69% -$170K ﹤0.01% 5409
2021
Q2
$6K Buy
5,400
+1,300
+32% +$91.9K ﹤0.01% 4337
2021
Q1
$39K Sell
4,100
-1,000
-20% -$82K ﹤0.01% 2618
2020
Q4
$101K Buy
5,100
+700
+16% +$51.6K ﹤0.01% 1525
2020
Q3
$34K Sell
4,400
-400
-8% -$20.3K ﹤0.01% 2061
2020
Q2
$8K Buy
+4,800
New +$174K ﹤0.01% 3037
2020
Q1
Sell
-27,700
Closed -$45K 4551
2019
Q4
$45K Buy
27,700
+16,200
+141% +$1.99M ﹤0.01% 1695
2019
Q3
$77K Buy
11,500
+5,000
+77% +$836K 0.01% 1229
2019
Q2
$187K Sell
6,500
-29,800
-82% -$5.08M 0.02% 751
2019
Q1
$481K Buy
36,300
+12,500
+53% +$1.81M 0.05% 323
2018
Q4
$153K Buy
23,800
+15,700
+194% +$1.8M 0.01% 788
2018
Q3
$149K Buy
8,100
+1,300
+19% +$201K 0.01% 990
2018
Q2
$144K Sell
6,800
-1,700
-20% -$267K 0.01% 934
2018
Q1
$202K Sell
8,500
-51,400
-86% -$8.73M 0.02% 820
2017
Q4
$3.97M Sell
59,900
-10,500
-15% -$1.02M 0.16% 77
2017
Q3
$411K Buy
70,400
+14,100
+25% +$1.11M 0.02% 752
2017
Q2
$525K Sell
56,300
-800
-1% -$57.8K 0.02% 664
2017
Q1
$431K Buy
57,100
+42,600
+294% +$2.5M 0.02% 714
2016
Q4
$85K Sell
14,500
-45,200
-76% -$2.13M ﹤0.01% 2057
2016
Q3
$227K Buy
59,700
+13,500
+29% +$550K 0.01% 1098
2016
Q2
$93K Buy
46,200
+36,900
+397% +$1.23M ﹤0.01% 1745
2016
Q1
$12K Buy
9,300
+5,100
+121% +$180K ﹤0.01% 3869
2015
Q4
$30K Buy
+4,200
New +$208K ﹤0.01% 2996

Other funds holding SAGE